Early detection of lung function decrements in children and adolescents with cystic fibrosis using new reference values

被引:0
作者
Angela Zacharasiewicz
Sabine Renner
Flora Haderer
Michael Weber
Eleonore Dehlink
Zsolt Szepfalusi
Thomas Frischer
机构
[1] Wilhelminenspital Vienna,Department of Pediatrics and Adolescent Medicine
[2] Medical University Hospital Vienna,Department of Pediatrics
[3] Medical University Vienna,Department of Biomedical Imaging and Image Guided Therapy
[4] The Royal Brompton Hospital,Department of Pediatrics
来源
Wiener klinische Wochenschrift | 2017年 / 129卷
关键词
Cystic fibrosis; Children; Spirometry; Lung function; Reference values;
D O I
暂无
中图分类号
学科分类号
摘要
Interpretation of lung function values in children with cystic fibrosis (CF) depends on the applied reference values. We hypothesize that differences between the new global lung function initiative (GLI) values and the formerly used Zapletal et al. values produce significantly different clinical results. We analyzed 3719 lung function measurements of 108 children and adolescents (n = 54 male; aged 6–18 years) with CF treated between September 1991 and July 2009. Data were analyzed in milliliters (ml) and % predicted (pred.) and interpreted using Zapletal and GLI reference values. Applying GLI compared to Zapletal resulted in significantly lower mean forced expiratory volume in 1s (FEV1)% pred. values: Zapletal 86.6% (SD 20.6), GLI 79.9% (SD 20.3) and 32% (n = 497/1543) were misclassified as normal when using Zapletal. Despite showing no overall differences in FEV1 and forced vital capacity (FVC) between concomitant Pseudomonas detection (PA+) in n = 938 and Pseudomonas negative (PA-) (n = 2781) using either reference PA+ resulted in lower FEV1 and FVC values with increasing age; however, measurement of small airway obstruction with forced expiratory flow at 75% of FVC (FEF75) values – available for Zapletal –showed significant differences. Reassurance regarding lung function when using old reference values may occur with potential clinical significance. Discrepancies in lung function interpretation underline the importance of using uniform and best available reference values.
引用
收藏
页码:533 / 539
页数:6
相关论文
共 98 条
[1]  
Gibson RL(2003)Pathophysiology and management of pulmonary infections in cystic fibrosis Am J Respir Crit Care Med 168 918-951
[2]  
Burns JL(1997)Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis J. Pediatr. 131 809-814
[3]  
Ramsey BW(2003)Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis Pediatr. Pulmonol. 36 230-240
[4]  
Corey M(2009)Monitoring respiratory disease severity in cystic fibrosis Respir Care 54 606-617
[5]  
Edwards L(2004)Repeatability of spirometry in 18,000 adult patients Am J Respir Crit Care Med 169 235-238
[6]  
Levison H(2003)Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis Eur Respir J 22 972-979
[7]  
Knowles M(2012)Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations Eur. Respir. J. 40 1324-1343
[8]  
Farrell PM(2014)The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry J Cyst Fibros 13 319-327
[9]  
Li Z(2013)Author’s response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study Thorax 68 294-295
[10]  
Kosorok MR(2007)Power considerations for studies of lung function in cystic fibrosis Proc Am Thorac Soc 4 334-337